BDS fails to prevent Israeli professor receiving British honor

June 28, 2016 15:30
1 minute read.


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


The BDS movement has not prevented Prof. Eitan Kerem, director of the pediatric branch at Hadassah University Medical Centers, from being elected to an honorary fellowships of Britain’s Royal College of Paediatrics and Child health, in recognition of his expertise as a leading researcher of cystic fibrosis (CF).

CF is a hereditary disorder affecting the exocrine glands that triggers the production of abnormally thick mucus, leading to the blockage of the pancreatic ducts, intestines and bronchi and often resulting in respiratory infection. Many victims eventually require lung transplants.Kerem received the honor this week in Liverpool at an impressive ceremony in which he was praised for his “pathfinding research in the field and his endless struggle for the rights of children wherever they are.”

The Jerusalem pediatrician was also cited for his globally recognized humanitarian contributions and advancing peace by bridging the gap between Israeli and Palestinian children in his CF clinic.

He was the first to prove that one can bypass genetic defects in patients with CF, and induce the functioning of defective proteins from birth. He was also a partner in the process of setting standards to create a seal of approval for the treatment of CF in Europe and around the world.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

Breaking news
January 22, 2019
Netanyahu: Israel's punch will reach any place